Insights on Chemical & Life Sciences

On April 25, the US Court of Appeals for the Third Circuit issued its precedential opinion in Mallinckrodt v. Sanofi-Aventis, Case No. 23-1111.

Janine Carlan will co-panel a discussion on “Key Focus on Winning Patent Litigation Strategies,” on March 2, 2023 at 10 AM, IST

ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual Managing IP Americas Awards.

The Biden Administration is using a comprehensive set of tools to stick closely to campaign promises around — and the public demand for — climate action.

ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual LMG Life Sciences Americas Awards.

Personalized medicine patent claims have been under assault since the Supreme Court’s Mayo v. Prometheus decision.

This year brought us very significant changes in patent jurisprudence from the Supreme Court and Federal Circuit affecting Chemical & Life Sciences patent practice.

On April 28, Arent Fox LLP attorney Alexander H. Spiegler secured a final written decision in favor of Gowan Company.

As in previous years, 2016 brought us a combination of both expected and unexpected holdings by the Supreme Court and the Federal Circuit.

Arent Fox filed an amici brief on behalf of the Wisconsin Alumni Research Foundation, the Indiana University Research and Technology Corporation, and San Diego Intellectual Property Law Association. Our brief focused on the following three errors in the Federal Circuit’s rationale.

As in previous years, 2015 brought a combination of expected and unexpected holdings by the Supreme Court and the Federal Circuit.

Arent Fox Intellectual Property partner Marylee Jenkins was quoted in numerous news outlets following her oral argument before the Supreme Court of the United States yesterday in a case over the legality of patenting human genes.